A single dose of sotrovimab was found to reduce the risk of hospitalisation and death by 79 percent in high-risk adults with symptomatic COVID, according to the UK’s medicines regulator [File: Toby Melville/Reuters]
ADVERTISEMENT
UK’s medicines regulator
UK's medicines regulator
Facetvnews
News $ Entertainment
We bring you the best new and entertainment, etc. Check our landing page for details. Download the app
